Previous Article | Next Article 
Journal of Clinical Microbiology, January 1999, p. 35-38, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Development of a Plasmodium PCR for
Monitoring Efficacy of Antimalarial Treatment
Liliane
Ciceron,1,*
Ginette
Jaureguiberry,2
Frederick
Gay,1 and
Martin
Danis1
Service de Parasitologie et Unité
INSERM 313, Centre Hospitalier-Universitaire
Pitié-Salpêtrière, 75013 Paris,1 and
EP 1790 CNRS,
Laboratoire de Biologie Parasitaire, MNHN, 75005 Paris,2 France
Received 11 May 1998/Returned for modification 22 July
1998/Accepted 14 October 1998
 |
ABSTRACT |
We report in this work a highly sensitive and nonradioactive PCR
method for the detection of the four species of parasite causing human
malaria. Plasmodium-specific primers corresponding to the
small-subunit rRNA genes of the malaria parasite were used, and a
291-bp fragment was amplified. Our results showed a high specificity
for the four human Plasmodium species, and we were able to
detect one parasite in 50 µl of whole blood. The responses of 12 patients infected with Plasmodium falciparum to
antimalarial therapy were monitored by PCR diagnosis and examination of
thick blood film for at least 20 min by an experienced microscopist. For one patient this study allowed early diagnosis of therapeutic failure, confirmed 7 days later by examination of the thick blood film.
A total of 134 samples were examined; 94 were positive by PCR, and
among these 68 were positive by thick blood film examination. The
sensitivity of the thick blood film was 72.3% compared to PCR and
60.7% compared to dot blot hybridization.
 |
INTRODUCTION |
In recent years, new techniques for
visualizing malaria parasites have been proposed. The quantitative
buffy coat malaria test and acridine orange-stained thick or thin blood
film (7, 12) use acridine orange as a fluorochrome to stain
parasite nucleic acids, but this fluorochrome is not specific and
stains nucleic acids from all cell types. The dipstick test (Parasight F test) is an immunological method specific for the detection of
Plasmodium falciparum, based on the presence in the blood of parasite histidine-rich protein 2 antigen (4);
consequently, Parasight F gives negative results for samples
containing Plasmodium vivax, Plasmodium ovale, or
Plasmodium malariae. Therefore, the specificity limitations
presented by these procedures leave the microscopic examination of
Giemsa-stained blood smears as the main method for diagnosis of malaria
infection in the field (6). However, this technique is not a
very satisfactory standard, as it is time-consuming and requires an
experienced microscopist and because its sensitivity in detecting very
low-level parasitemia is limited.
To overcome this problem, enzymatic amplification of DNA by PCR and
amplification by the reverse transcriptase PCR (1, 13) have
been successfully developed and used as highly sensitive diagnostic
methods. The first studies of nucleic acid-based malaria detection used
the repetitive genomic DNA as a target (3, 22). To date, the
main sequences of DNA that are amplified are those in the genes
encoding the surface antigens (19, 24, 28), the 18S rRNA
gene (10, 15), and the dihydrofolate reductase-thymidylate synthetase gene (2, 26).
In this study we have developed a simple and highly sensitive DNA
diagnostic method without organic extraction and using a digoxigenin-11-dUTP-labeled probe. We chose the rRNA as a diagnostic target, particularly the small-subunit (SSU) rRNA gene. The sequence of
the SSU rRNA gene is composed of a mosaic of conserved and variable
regions; this type of arrangement allows the amplification of a
sequence from a sample with primers that are conserved within every
member of the genus Plasmodium (13, 27). The
chosen primers allowed the amplification of both asexual and sexual
sequences of the 18S rRNA genes of the four human malaria parasites;
the length of amplified DNA was predicted at 291 bp. This method was used to monitor antimalarial therapy in 12 patients. Results of thick
blood films and PCR for each sample were compared.
 |
MATERIALS AND METHODS |
Genus specificity.
To amplify the DNA of the four human
Plasmodium species, blood samples containing P. vivax (5 samples), P. ovale (12 samples), P. malariae (3 samples), and P. falciparum (56 samples)
from patients with acute malaria were collected. Each sample was
collected from a single patient and no mixed infection was found.
Moreover, for the genus specificity, we lysed in vitro cultures of
other protozoa such as Toxoplasma gondii, Leishmania
infantum, and Trypanosoma cruzi for DNA amplification.
Level of detection. (i) Absolute sensitivity.
To determine
the sensitivity of the PCR, asynchronous cultures of P. falciparum NF54 were cultured by the method of Trager and Jensen
(23) and harvested when the level of parasitemia was between
5 and 10%. DNA was extracted by the procedure described by Goman et
al. (8). Briefly, infected erythrocytes 1× SSC solution
(0.15 M NaCl, 0.015 M sodium citrate [pH 7]) containing 0.01%
saponin were lysed at 37°C for 20 min. The lysate was digested with 1 mg of proteinase K (Boehringer Mannheim, Meylan, France) per ml in the
presence of 4% sodium N lauroylsarcosine (Sigma) in 1× SSC
by incubation for 1 h at 37°C. Parasite DNA was extracted with
phenol-chloroform and precipitated with ethanol according to the method
described by Maniatis et al. (14). The DNA concentration was
determined spectrophotometrically, and 10-fold serial dilutions of
P. falciparum DNA (10 to 0.001 pg) were used as positive controls.
To establish the minimum number of parasites that could be detected,
blood samples from three patients infected with P. falciparum were collected. The parasitemia was adjusted to 1% and
hematocrit was standardized to 50%. The infected blood was diluted
with uninfected erythrocytes from healthy individuals. Ten-fold serial
dilutions were made to obtain a final parasitemia level of
10
8% (one parasite/1010 erythrocytes).
Samples were treated in duplicate.
(ii) Relative sensitivity. (a) Blood sample collection and
microscopy.
Blood samples were collected by venipuncture from 12 nonimmune P. falciparum-infected patients admitted to the
Pitié-Salpêtrière Hospital with acute uncomplicated
P. falciparum malaria. These patients were included in a
randomized, double-blind, parallel-group clinical trial to compare the
efficacy of a new combination of antimalarial drugs with that of
halofantrine. The patients were hospitalized for 3 days and blood
samples were collected for each patient. Thick and thin peripheral
blood smears were taken at 0, 4, 8, 12, 24, 32, 48, 52, 56, and 60 h after the start of treatment and subsequently on days 8, 15, 21, and
29. Thin and thick blood films (one slide each) were Giemsa stained and
examined by an experienced microscopist for at least 20 min before the
samples were declared negative. The microscopist was unaware of the
patient treatment status. Parasitemia was expressed as number of
parasites per microliter by using the leukocyte count per microliter
and number of infected erythrocytes (thin blood film) or number of parasites (thick blood film) per 200 leukocytes.
(b) Sample treatment.
Fifty microliters of whole blood was
transferred into a 0.5-ml centrifuge tube containing 500 µl of lysis
buffer (0.2% NaCl, 1% Triton X-100, 1 mM EDTA) and mixed at room
temperature by inverting the tube to ensure complete lysis of the
erythrocytes. The mixture was centrifuged at 11,300 × g
(Mikroliter 2041; Hettich) at 4°C for 10 min and the supernatant was
removed. The pellet was washed with 300 µl of PCR buffer (10 mM
Tris-HCl [pH 9], 50 mM KCl, 2.5 mM MgCl2, 0.01% gelatin,
0.1% Triton X-100) and centrifuged at 10,000 rpm for 5 min. The pellet
of each sample was stored at
20°C before PCR amplification.
Oligonucleotide primers and labeled probe.
Oligonucleotides
were synthesized by Eurogentec (Seraing, Belgium). Two primers were
designed according to the primary sequence of the SSU rRNA gene of
P. falciparum (9). The forward primer corresponded position 919 to 939 of the sequence
(5'-AGTTACGATTAATAGGAGTAG-3') (10), and the
reverse primer corresponded to position 1180 to 1201 on the
complementary strand (5'-CCAAAGACTTTGATTTCTCAT-3'). An
internal oligonucleotide probe
(5'-GAACGAAAGTTAAGGGAG TGAAGACG-3') was labeled with
digoxigenin-11-dUTP by using the digoxigenin oligonucleotide tailing
kit (Boehringer Mannheim) according to the manufacturer's instructions.
PCR amplification.
Amplification was carried out in a DNA
thermal cycler (Hybaid) according to the method of Saiki et al., with
modifications (18). The washed pellets were resuspended in
80 µl of the PCR buffer described above containing a 0.2 µM
concentration of each primer. The samples were overlaid with 70 µl of
mineral oil and boiled at 100°C for 10 min before addition of 1 U of
Taq polymerase (ATGC, Noisy le Grand, France) and a 200 µM
concentration of each deoxynucleotide triphosphate in 20 µl of PCR
buffer. Samples were amplified in duplicate. The PCR program ran for 40 cycles under the following conditions: 30 s at 94°C, 30 s
at 55°C, and 1 min at 72°C, with exception of the first cycle, in
which the denaturation was carried out for 5 min, and for the last
cycle, in which the elongation time was extended to 10 min. Each
experiment included control tubes corresponding to a serial dilution of
(i) positive controls consisting of P. falciparum genomic
DNA and (ii) a negative control containing no target DNA.
Detection of PCR products.
Twenty microliters of the PCR
product was electrophoresed in a 2% agarose gel containing 0.1 µg of
ethidium bromide per ml, and bands were visualized by UV
transillumination. For Southern blot hybridization, amplified DNA was
transferred from the agarose gel to a positively charged nylon membrane
(Hybond+; Amersham, Les Ulis, France) by the method of Southern
(21). The PCR sample was prehybridized for 1 h at
50°C in hybridization buffer containing 5× SSC, 0.1% (wt/vol)
N-lauroylsarcosine, 0.02% (wt/vol) sodium dodecyl sulfate
(SDS), and a 1% concentration of the blocking reagent recommended by
Boehringer Mannheim. Hybridization was carried out overnight at 50°C
in the same buffer with 0.5 or 1 pmol of the labeled probe per ml. The
blot was then washed twice for 5 min each time in 2× SSC-0.1% SDS at
room temperature and twice for 15 min each time in 0.5× SSC-0.1% SDS
at 50°C. Bound digoxigenin-11-dUTP-labeled probe was detected by
using a digoxigenin luminescent detection kit (Boehringer Mannheim).
The membrane was autoradiographed on Hyperfilm ECL (Amersham) for 15 to
30 min.
 |
RESULTS |
Genus specificity.
The chosen primers were able to amplify
both asexual and sexual sequences of the 18S rRNA genes of the four
human malaria parasites. The 291-bp PCR fragments of the four human
Plasmodium species were visualized by agarose gel
electrophoresis, and the amplified DNA gave a strong signal with the
oligonucleotide digoxigenin-labeled probe in Southern blot
hybridization. No signal was detected by PCR or Southern blot analysis
for the other parasites tested (Toxoplasma, Leishmania, and Trypanosoma) or with the human
DNA (Fig. 1).

View larger version (102K):
[in this window]
[in a new window]
|
FIG. 1.
Determination of the genus specificity of PCR. (A)
Analysis by agarose gel electrophoresis and ethidium bromide staining.
(B) Southern blot and hybridization with a digoxigenin-11-dUTP-labeled
probe. Lane 1, X174 DNA cleaved with HaeIII as a
molecular size marker, lane 2, L. infantum (106
organisms); lane 3, T. gondii (106 organisms);
lane 4, T. gondii DNA (1 µg); lane 5, human DNA (1 µg);
lane 6, T. cruzi (106 organisms); lane 7, P. vivax (0.3%); lane 8, P. ovale (0.1%); lane
9, P. malariae (1%); lane 10, pBR322 DNA cleaved with
HaeIII as a molecular size marker; lane 11, P. falciparum (0.5%). Arrows at the right indicate the 291-bp PCR
product.
|
|
Level of detection. (i) Absolute sensitivity.
Over 20 tests,
the sensitivity of the PCR was determined with P. falciparum
DNA obtained by phenol-chloroform extraction with a 10-fold
dilution standard down to 1 fg (10
15 g). A visible signal
was detected in 30% of cases at 0.001 pg of DNA and in 55% of
cases at 0.01 pg of DNA (a genome equivalent of the parasite is 0.02 pg
according to Goman et al. [8]) (Table 1).
Sensitivity was also measured by using a limited dilution of a single
P. falciparum isolate, from 1 to 10
8%. The
PCR was able to detect 5 parasites (patient 1), 12.5 parasites
(patient
2), and 0.25 parasite (patient 3) (corresponding to 0.1,
0.25, and
0.005 parasite/µl) in 50 µl of whole blood at 50% hematocrit
(5 × 10
6 erythrocytes/µl). Results for patient 3 are showed in Fig.
2.

View larger version (110K):
[in this window]
[in a new window]
|
FIG. 2.
Determination of the absolute sensitivity of PCR. (A)
Analysis by agarose gel electrophoresis. (B) Southern blot
hybridization with a digoxigenin-11-dUTP-labeled probe. Lane 1, pBR322
DNA cleaved with HaeIII as a molecular size marker; lanes 2 to 10, 10-fold dilutions of a single isolate with uninfected
erythrocytes (1 to 10 8%). Arrows at the right indicate
the 291-bp PCR product.
|
|
(ii) Relative sensitivity.
Our technique was applied to
compare the results of the thick blood film and PCR in a series of 135 samples from 12 patients treated with a new antimalarial combination.
The results showed that the thick blood film had a lower sensitivity
than the PCR diagnosis. We therefore calculated the sensitivity of
Giemsa staining with respect to the PCR results (Table
2). The thick blood film was negative for
27.7% of samples shown to be PCR positive by ethidium bromide
staining. For all PCR-negative samples the thick blood films were also
negative. Samples (n = 134) from these patients were
tested by dot blot hybridization (Table
3), and the 291-bp segment specific for
the Plasmodium genus was amplified in samples from all 12 patients at day 0. We observed that PCR yields positive results longer
than microscopic examinations. The median times to clearance of
parasite DNA were 54 h with ethidium bromide staining and 192 h by dot blot hybridization. According to thick blood film the median
total clearance time was 32 h. For one patient PCR after ethidium
bromide staining or dot blot hybridization yielded positive results
until day 19, although the microscopic examination was negative at day
5. One week later, this patient, who had received the combination of
antimalarial drugs, consulted the department again with headache and
asthma without fever. P. falciparum was diagnosed by
microscopic examination (600 trophozoites/µl). To cure the relapse he
was given one dose of halofantrine. The thick blood films were negative
on days 18, 21, and 28, but the PCR yielded a positive result on day
18, giving negative results only on days 21 and 28. For another patient
dot blot hybridization yielded positive results until day 15 and a
thick blood film was negative at day 2, but no failure of treatment was
observed more than 4 weeks after the start of therapy.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Sensitivities of the thick blood
filma and PCR diagnosis with dot blot
hybridization with a digoxigenin-11-dUTP-labeled probe
|
|
 |
DISCUSSION |
To date PCR has been a powerful tool for malaria diagnosis. Many
studies have demonstrated the greater sensitivity and specificity of
PCR than of the thick blood film. However, microscopic detection remains the most reliable standard. The techniques for detecting specific PCR products (gel electrophoresis with ethidium bromide staining and dot blot hybridization) are not compatible with those used
in routine diagnostic laboratories which require a prompt diagnosis
for initiating treatment of severe or acute malaria in patients
with clinical symptoms. Other applications have been proposed: the
detection of asymptomatic carriers in areas of endemicity (2) or during epidemiological studies (17, 29),
the monitoring of patient responses to antimalarial drugs, and genotype
characterization (16, 28).
We wanted to develop a fast, sensitive PCR method for detecting
all four human malaria species to screen blood donors in areas of
endemicity. Most PCR diagnostic assays use organic extraction with
phenol-chloroform and ethanol precipitation of DNA from blood samples. This method is not practical for large numbers of samples: it
is time-consuming and requires the use of hazardous chemical products.
To overcome this problem, several methods of sample preparation
have been developed: saponin lysis and filtration or centrifugation,
direct spotting on a membrane with lysis with distilled water,
and boiling in the presence of a chelating resin (Chelex 100).
All these procedures are simple and give similar results. We therefore
selected the method proposed by Vu et al. (25), which
requires only erythrocyte lysis followed by centrifugation.
Almost all PCR methods reported detect only P. falciparum,
which is the most virulent species, or use one set of primers for each
human malaria species (20) or species-specific probe.
Because of our concern with screening blood donors, we considered a
method which allows the detection of all human parasite species with a
single probe preferable to those detecting only one species, considering the morbidity associated with other types of malaria. We
were able to detect the four human malaria species with a single set of
primers. The chosen amplified target was a region of the SSU rRNA gene
conserved within every member of the genus Plasmodium. This
method is also very sensitive, as we were able to detect a single
parasite in 50 µl of whole blood. Since the thick blood film
detection limit corresponds to five parasites/µl, the sensitivity of
PCR detection is, on average, 250 times greater. The PCR diagnosis method therefore permits the detection of more cases of low-level parasitemia than thick blood film examination (5), and its use for blood screening can minimize the risk of malaria transmission by blood transfusion in areas of endemicity (25).
PCR diagnosis has also been used for monitoring antimalarial
therapeutic responses and chemoresistance. Previous studies
showed that if PCR yields positive results for 5 to 8 days after
treatment, therapeutic failure possibly due to parasite resistance may
be predicted (11). The World Health Organization has defined
four degrees of resistance (S, RI, RII, and RIII) based on the
evolution of parasitemia detected by microscopic examination of thick
blood films. It is likely that the greater sensitivity of PCR modifies the classification criteria, as there is the possibility that an RI
resistance pattern as defined by microscopy could be reclassified as an
RII pattern when PCR is employed. Hence, early identification of
the type of parasite resistance would permit an appropriate therapy change. In conclusion, this rapid and accurate test for P. falciparum and other plasmodial species may facilitate
early diagnosis and initiation of appropriate antimalarial therapy.
The PCR method has been previously demonstrated to be sensitive and
specific for diagnosis of malaria and may be preferable to microscopy
as the reference standard for evaluating new diagnostic tests. On the
basis of the first step of our study, which has demonstrated the 100%
specificity and the high absolute sensitivity of the PCR compared to
the Giemsa-stained thick smear based on a serial dilution, we have
chosen PCR as our standard. Therefore, we classified every negative
thick smear corresponding to a positive PCR result as a false negative,
and this classification is corroborated by the early PCR detection of
treatment failure.
 |
ACKNOWLEDGMENTS |
We are grateful to Antoine Minaret and Marie-Paule Nivez for
technical assistance and to Caroline Doerig and Jacques Breton for
reviewing the manuscript.
This study was supported by a grant from the Raoul
Follereau Association.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unité
INSERM 313, CHU Pitié-Salpêtrière, 47 Bld. de
l'Hôpital, 75013 Paris, France. Phone: 33-1-42-16-01-47. Fax: 33-1-42-16-01-65. E-mail:
martin.danis{at}psl.ap-hop-paris.fr.
 |
REFERENCES |
| 1.
|
Abdullah, N. R.,
T. Furuta,
R. Taib,
K. Kita,
S. Kojima, and M. J. Wah.
1996.
Short report: development of a new diagnostic method for Plasmodium falciparum infection using a reverse transcriptase-polymerase chain reaction.
Am. J. Trop. Med. Hyg.
54:162-163.
|
| 2.
|
Arai, M.,
C. Mizukoshi,
F. Kubochi,
T. Kakutani, and Y. Wataya.
1994.
Detection of Plasmodium falciparum in human blood by a nested polymerase chain reaction.
Am. J. Trop. Med. Hyg.
51:617-626.
|
| 3.
|
Barker, R. J.,
T. Banchongaksorn,
J. M. Courval,
W. Suwonkerd,
K. Rimwungtragoon, and D. F. Wirth.
1992.
A simple method to detect Plasmodium falciparum directly from blood samples using the polymerase chain reaction.
Am. J. Trop. Med. Hyg.
46:416-426.
|
| 4.
|
Beadle, C.,
G. W. Long,
W. R. Weiss,
P. D. McElroy,
S. M. Maret,
A. J. Oloo, and S. L. Hoffman.
1994.
Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay.
Lancet
343:564-568[Medline].
|
| 5.
|
Bottius, E.,
A. Guanzirolli,
J. Trape,
C. Rogier,
L. Konate, and P. Druilhe.
1996.
Malaria: even more chronic in nature than previously thought; evidence for subpatient parasitaemia detectable by the polymerase chain reaction.
Trans. R. Soc. Trop. Med. Hyg.
90:15-19[Medline].
|
| 6.
|
Craig, M. H., and B. L. Sharp.
1997.
Comparative evaluation of four techniques for the diagnosis of Plasmodium falciparum infections.
Trans. R. Soc. Trop. Med. Hyg.
91:279-282[Medline].
|
| 7.
|
Gay, F.,
B. Traore,
J. Zanoni,
M. Danis, and A. Fribourg-Blanc.
1996.
Direct acridine orange fluorescence examination of blood slides compared to current techniques for malaria diagnosis.
Trans. R. Soc. Trop. Med. Hyg.
90:516-518[Medline].
|
| 8.
|
Goman, M.,
G. Langsley,
J. E. Hyde,
N. K. Yankovsky,
J. W. Zolg, and J. G. Scaife.
1982.
The establishment of genomic DNA libraries for the human malaria parasite Plasmodium falciparum and identification of individual clones by hybridization.
Mol. Biochem. Parasitol.
5:391-400[Medline].
|
| 9.
|
Goman, M.,
B. Mons, and J. Scaife.
1991.
The complete sequence of a Plasmodium malariae SSUrRNA gene and its comparison to other plasmodial SSUrRNA genes.
Mol. Biochem. Parasitol.
45:281-288[Medline].
|
| 10.
|
Jaureguiberry, G.,
I. Hatin,
L. d'Auriol, and G. Galibert.
1990.
PCR detection of Plasmodium falciparum by oligonucleotide probes.
Mol. Cell. Probes
4:409-414[Medline].
|
| 11.
|
Kain, K. C.,
D. E. Kyle,
C. Wongsrichanalai, and A. E. Brown.
1994.
Qualitative and semiquantitative polymerase chain reaction to predict Plasmodium falciparum treatment failure.
J. Infect. Dis.
170:1626-1630[Medline].
|
| 12.
|
Kawamoto, F.
1991.
Rapid diagnosis of malaria by fluorescence microscopy with light microscope and interference filter.
Lancet
337:200-202[Medline].
|
| 13.
|
Li, J.,
R. A. Wirtz,
G. A. McConkey,
J. Sattabongkot,
A. P. Waters,
M. J. Rogers, and T. F. McCutchan.
1995.
Plasmodium: genus-conserved primers for species identification and quantification.
Exp. Parasitol.
81:182-190[Medline].
|
| 14.
|
Maniatis, T.,
E. F. Fritsch, and J. Sambrook.
1982.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 15.
|
McCutchan, T. F.,
V. F. De La Cruz,
A. A. Lal,
J. H. Gunderson,
H. J. Elwood, and M. L. Sogin.
1988.
Primary sequences of two small subunit ribosomal RNA genes from P. falciparum.
Mol. Biochem. Parasitol.
28:63-68[Medline].
|
| 16.
|
Mercereau-Puijalon, O.,
T. Fandeur,
S. Bonnefoy,
C. Jacquemot, and J.-L. Sarthou.
1991.
A study of the genomic diversity of Plasmodium falciparum in Senegal 2. Typing by the use of the polymerase chain reaction.
Acta. Trop.
49:293-304[Medline].
|
| 17.
|
Roper, C.,
I. M. Elhassan,
L. Hviid,
H. Giha,
W. Richardson,
H. Babiker,
G. M. H. Satti,
T. G. Theander, and D. E. Arnot.
1996.
Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan.
Am. J. Trop. Med. Hyg.
54:325-331.
|
| 18.
|
Saiki, R. K.,
S. Scharf,
F. Faloona,
K. B. Mullis,
G. T. Horn,
H. A. Erlich, and N. Arnheim.
1985.
Enzymatic amplification of -globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.
Science
230:1350-1354[Abstract/Free Full Text].
|
| 19.
|
Sethabutr, O.,
A. E. Brown,
S. Panyim,
K. C. Kain,
K. Webster, and P. Echeverria.
1992.
Detection of Plasmodium falciparum by polymease chain reaction in a field study.
J. Infect. Dis.
166:145-148[Medline].
|
| 20.
|
Snounou, G.,
S. Viriyakosol,
X. P. Zhu,
W. Jarra,
L. Pinheiro,
V. E. do Rosario,
S. Thaithong, and K. N. Brown.
1993.
High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction.
Mol. Biochem. Parasitol.
61:315-320[Medline].
|
| 21.
|
Southern, E. M.
1975.
Detection of specific sequences among DNA fragments separated by gel electrophoresis.
J. Mol. Biol.
98:503-517[Medline].
|
| 22.
|
Tirasophon, W.,
P. Rajkulchai,
M. Ponglikitmongkol,
P. Wilairat,
V. Boonsaeng, and S. Panyin.
1994.
A highly sensitive, rapid, and simple polymerase chain reaction-based method to detect human malaria (Plasmodium falciparum and Plasmodium vivax) in blood samples.
Am. J. Trop. Med. Hyg.
51:308-313.
|
| 23.
|
Trager, W., and J. B. Jensen.
1976.
Human malaria parasites in continuous culture.
Science
193:673-675[Abstract/Free Full Text].
|
| 24.
|
Viriyakosol, S.,
N. Siripon,
X. P. Zhu,
W. Jarra,
A. Seugorn,
K. N. Brown, and G. Snounou.
1994.
Plasmodium falciparum: selective growth of subpopulations from field samples following in vitro culture, as detected by the polymerase chain reaction.
Exp. Parasitol
79:517-525[Medline].
|
| 25.
|
Vu, T. T.,
V. B. Tran,
N. T. Phan,
T. T. Le,
V. H. Luong,
E. O'Brien, and G. E. Morris.
1995.
Screening donor blood for malaria by polymerase chain reaction.
Trans. R. Soc. Trop. Med. Hyg.
89:44-47[Medline].
|
| 26.
|
Wataya, Y.,
M. Arai,
F. Kubochi,
C. Mizukoshi,
T. Kakutani,
N. Ohta, and A. Ishii.
1993.
DNA diagnosis of falciparum malaria using a double PCR technique: a filed trial in the Solomon Islands.
Mol. Biochem. Parasitol.
58:165-168[Medline].
|
| 27.
|
Waters, A. P., and T. F. McCutchan.
1989.
Rapid, sensitive diagnosis of malaria based on ribosomal RNA.
Lancet
i:1343-1346.
|
| 28.
|
Wooden, J.,
E. E. Gould,
A. T. Paull, and C. H. Sibley.
1992.
Plasmodium falciparum: a simple polymerase chain reaction method for differentiating strains.
Exp. Parasitol.
75:207-212[Medline].
|
| 29.
|
Zalis, M. G.,
M. F. Ferreira da Cruz,
H. C. Balthazar-Guedes,
D. M. Banic,
W. Alecrim,
J. M. Souza,
P. Druilhe, and C. T. Daniel-Ribeiro.
1996.
Malaria diagnosis: standardization of a polymerase chain reaction for the detection of Plasmodium falciparum parasites in individuals with low-grade parasitemia.
Parasitol. Res.
82:612-616[Medline].
|
Journal of Clinical Microbiology, January 1999, p. 35-38, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Beurskens, M., Mens, P., Schallig, H., Syafruddin, D., Asih, P. B. S., Hermsen, R., Sauerwein, R.
(2009). Quantitative Determination of Plasmodium vivax Gametocytes by Real-Time Quantitative Nucleic Acid Sequence-Based Amplification in Clinical Samples. Am J Trop Med Hyg
81: 366-369
[Abstract]
[Full Text]
-
AYALA, E., LESCANO, A. G., GILMAN, R. H., CALDERON, M., PINEDO, V. V., TERRY, H., CABRERA, L., VINETZ, J. M.
(2006). POLYMERASE CHAIN REACTION AND MOLECULAR GENOTYPING TO MONITOR PARASITOLOGICAL RESPONSE TO ANTI-MALARIAL CHEMOTHERAPY IN THE PERUVIAN AMAZON. Am J Trop Med Hyg
74: 546-553
[Abstract]
[Full Text]
-
Elsayed, S., Plewes, K., Church, D., Chow, B., Zhang, K.
(2006). Use of Molecular Beacon Probes for Real-Time PCR Detection of Plasmodium falciparum and Other Plasmodium Species in Peripheral Blood Specimens. J. Clin. Microbiol.
44: 622-624
[Abstract]
[Full Text]
-
Mangold, K. A., Manson, R. U., Koay, E. S. C., Stephens, L., Regner, M., Thomson, R. B. Jr., Peterson, L. R., Kaul, K. L.
(2005). Real-Time PCR for Detection and Identification of Plasmodium spp.. J. Clin. Microbiol.
43: 2435-2440
[Abstract]
[Full Text]
-
Schneider, P., Wolters, L., Schoone, G., Schallig, H., Sillekens, P., Hermsen, R., Sauerwein, R.
(2005). Real-Time Nucleic Acid Sequence-Based Amplification Is More Convenient than Real-Time PCR for Quantification of Plasmodium falciparum. J. Clin. Microbiol.
43: 402-405
[Abstract]
[Full Text]
-
Rougemont, M., Van Saanen, M., Sahli, R., Hinrikson, H. P., Bille, J., Jaton, K.
(2004). Detection of Four Plasmodium Species in Blood from Humans by 18S rRNA Gene Subunit-Based and Species-Specific Real-Time PCR Assays. J. Clin. Microbiol.
42: 5636-5643
[Abstract]
[Full Text]
-
Schoone, G. J., Oskam, L., Kroon, N. C. M., Schallig, H. D. F. H., Omar, S. A.
(2000). Detection and Quantification of Plasmodium falciparum in Blood Samples Using Quantitative Nucleic Acid Sequence-Based Amplification. J. Clin. Microbiol.
38: 4072-4075
[Abstract]
[Full Text]